HIV Status and COVID-19 Treatment Disparities in the US National Clinical Cohort Collaborative.

ABSTRACT:

Background

While disparities in COVID-19 therapeutic access have been documented, the effect of HIV status on treatment access and how it intersects with other sociodemographic factors has not been well explored. Using data from the National Clinical Cohort Collaborative (N3C), we investigated disparities in COVID-19 therapeutic prescription among persons with HIV and without HIV.

Methods

This was a retrospective cohort study of patients' data from January 2020 to November 2024. The study included 7 806 412 patients with a COVID-19 diagnosis, of whom 45 508 (0.58%) were persons with HIV. We employed logistic and linear regression models to assess associations between therapeutic receipt and patient characteristics.

Results

Persons with HIV had significantly higher adj

SUBMITTER: Essam Nkodo EN 

PROVIDER: S-EPMC12805825 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature